← Leaderboards

Peter J O'Dwyer

University Of Pennsylvania

Google Scholar ↗PubMed ↗ORCID ↗

$138,294,037

Attributed

$236,177,113

Total exposure

28

Grants

23

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $57.1M · FY2005–25

$100M$75M$50M$25M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$338,067,639 · 28

FDA$4,472,227 · 1

By mechanism

U10$191,020,577 · 20

UG1$134,349,229 · 1

R01$7,102,094 · 4

U01$4,472,227 · 1

U24$2,951,674 · 1

P50$2,371,445 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Mitchell D Schnall$128,628,301
Rong Zhou$5,743,610
Mark Alan Rosen$7,909,168
David B. Hackney$4,113,862

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsClinical TrialsProgramsImageEastern Cooperative Oncology GroupAmerican College Of Radiology Imaging NetworkCancer TherapyOperationClinical ResearchCommunitiesCancer BiologyInfrastructureResearch PersonnelTranslatingLaboratoriesBiological MarkersFundingScienceBiobankCommunity Clinical Oncology ProgramBaseCancer PatientSiteInnovation

Grant awards (106)

ECOG-ACRIN NCORP Research Base$17,746,015

UG1 · FY2025 · CA

ECOG-ACRIN Network Group Operations Center$12,592,885

U10 · FY2025 · CA · contact PI

Member Site Core$6,452,854

U10 · FY2025 · CA · contact PI

Clinical Trials Development Core$4,462,716

U10 · FY2025 · CA · contact PI

Administrative Core$1,677,315

U10 · FY2025 · CA · contact PI

Member Site Core$508,000

U10 · FY2025 · CA · contact PI

ECOG-ACRIN Network Group Operations Center - EA4231 Supplement$508,000

U10 · FY2025 · CA · contact PI

ECOG-ACRIN NCORP Research Base$79,202

UG1 · FY2025 · CA

ECOG-ACRIN NCORP Research Base$18,695,221

UG1 · FY2024 · CA

ECOG-ACRIN Network Group Operations Center$9,437,815

U10 · FY2024 · CA · contact PI

Member Site Core$4,944,329

U10 · FY2024 · CA · contact PI

Clinical Trials Development Core$3,301,464

U10 · FY2024 · CA · contact PI

Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making$2,247,715

U01 · FY2024 · FD · contact PI

Administrative Core$1,192,022

U10 · FY2024 · CA · contact PI

ECOG-ACRIN Network Group Operations Center - BIQSFP$804,000

U10 · FY2024 · CA · contact PI

Clinical Trials Development Core$804,000

U10 · FY2024 · CA · contact PI

ECOG-ACRIN NCORP Research Base - TMIST$18,423,048

UG1 · FY2023 · CA

ECOG-ACRIN Network Group Operations Center$10,184,853

U10 · FY2023 · CA · contact PI

ECOG-ACRIN NCORP Research Base$5,154,867

UG1 · FY2023 · CA

Member Site Core$4,882,472

U10 · FY2023 · CA · contact PI

Clinical Trials Development Core$3,860,492

U10 · FY2023 · CA · contact PI

Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making$2,224,512

U01 · FY2023 · FD · contact PI

Administrative Core$1,441,889

U10 · FY2023 · CA · contact PI

Member Site Core$1,177,586

U10 · FY2023 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$1,177,586

U10 · FY2023 · CA · contact PI

NCTN Restricted Capitation - GY9$452,275

U10 · FY2023 · CA · contact PI

ECOG-ACRIN Network Group Operations Center - Supplement$412,356

U10 · FY2023 · CA · contact PI

Member Site Core$412,356

U10 · FY2023 · CA · contact PI

ECOG-ACRIN NCORP Research Base$26,214,534

UG1 · FY2022 · CA

ECOG-ACRIN Network Group Operations Center$11,926,283

U10 · FY2022 · CA · contact PI

Member Site Core$7,130,998

U10 · FY2022 · CA · contact PI

Clinical Trials Development Core$5,573,218

U10 · FY2022 · CA · contact PI

Administrative Core$2,129,352

U10 · FY2022 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$1,146,193

U10 · FY2022 · CA · contact PI

ECOG-ACRIN NCORP Research Base$945,901

UG1 · FY2022 · CA

Project-005$616,500

U10 · FY2022 · CA · contact PI

Penn Quantitative MRI Resource for Pancreatic Cancer$574,949

U24 · FY2022 · CA

ECOG-ACRIN NCORP Research Base$322,207

UG1 · FY2022 · CA

Project-003$203,100

U10 · FY2022 · CA · contact PI

Project-002$202,500

U10 · FY2022 · CA · contact PI

Project-004$124,093

U10 · FY2022 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$10,884,566

U10 · FY2021 · CA · contact PI

ECOG-ACRIN NCORP Research Base$7,343,401

UG1 · FY2021 · CA

Member Site Core$5,734,569

U10 · FY2021 · CA · contact PI

Clinical Trials Development Core$4,221,406

U10 · FY2021 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$1,316,230

U10 · FY2021 · CA · contact PI

Administrative Core$928,591

U10 · FY2021 · CA · contact PI

Penn Quantitative MRI Resource for Pancreatic Cancer$607,181

U24 · FY2021 · CA

Administrative Core$436,911

U10 · FY2021 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$436,911

U10 · FY2021 · CA · contact PI

ECOG-ACRIN NCORP Research Base$388,169

UG1 · FY2021 · CA

ECOG-ACRIN NCORP Research Base$385,270

UG1 · FY2021 · CA

Project-002$263,246

U10 · FY2021 · CA · contact PI

Project-006$263,246

U10 · FY2021 · CA · contact PI

Project-005$263,246

U10 · FY2021 · CA · contact PI

Project-003$263,246

U10 · FY2021 · CA · contact PI

Project-004$263,246

U10 · FY2021 · CA · contact PI

ECOG-ACRIN NCORP Research Base$17,691,650

UG1 · FY2020 · CA

ECOG-ACRIN Network Group Operations Center$8,078,785

U10 · FY2020 · CA · contact PI

Member Site Core$3,824,490

U10 · FY2020 · CA · contact PI

Clinical Trials Development Core$3,085,146

U10 · FY2020 · CA · contact PI

Administrative Core$1,199,931

U10 · FY2020 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$1,199,931

U10 · FY2020 · CA · contact PI

Administrative Core$1,169,149

U10 · FY2020 · CA · contact PI

Penn Quantitative MRI Resource for Pancreatic Cancer$607,181

U24 · FY2020 · CA

ECOG-ACRIN NCORP Research Base$392,177

UG1 · FY2020 · CA

ECOG-ACRIN NCORP Research Base$123,705

UG1 · FY2020 · CA

ECOG-ACRIN NCORP Research Base$20,443,862

UG1 · FY2019 · CA

ECOG-ACRIN Network Group Operations Center$10,562,444

U10 · FY2019 · CA · contact PI

Member Site Core$4,938,597

U10 · FY2019 · CA · contact PI

Clinical Trials Development Core$4,007,992

U10 · FY2019 · CA · contact PI

Administrative Core$1,615,855

U10 · FY2019 · CA · contact PI

ECOG-ACRIN Network Group Operations Center$1,081,701

U10 · FY2019 · CA · contact PI

Penn Quantitative MRI Resource for Pancreatic Cancer$588,964

U24 · FY2019 · CA

Administrative Core$274,293

U10 · FY2019 · CA · contact PI

Core-004$241,454

U10 · FY2019 · CA · contact PI

Member Site Core$236,038

U10 · FY2019 · CA · contact PI

Clinical Trials Development Core$205,778

U10 · FY2019 · CA · contact PI

Core-003$124,138

U10 · FY2019 · CA · contact PI

ECOG-ACRIN Operations Center$12,090,503

U10 · FY2018 · CA · contact PI

ECOG-ACRIN Operations Center$702,581

U10 · FY2018 · CA · contact PI

Penn Quantitative MRI Resource for Pancreatic Cancer$573,399

U24 · FY2018 · CA

ECOG-ACRIN Operations Center$11,366,855

U10 · FY2017 · CA · contact PI

Interaction of anti-angiogenic and cytotoxic therapies in colorectal cancer$511,559

R01 · FY2013 · CA · contact PI

Autophagy inhibition to sensitize colon cancer to anti-angiogenic therapy$505,800

R01 · FY2013 · CA · contact PI

Therapeutic Micro RNA Strategies for Ovarian Cancer$502,616

P50 · FY2013 · CA

Interaction of anti-angiogenic and cytotoxic therapies in colorectal cancer$636,010

R01 · FY2012 · CA · contact PI

Autophagy inhibition to sensitize colon cancer to anti-angiogenic therapy$539,500

R01 · FY2012 · CA · contact PI

Therapeutic Micro RNA Strategies for Ovarian Cancer$426,838

P50 · FY2012 · CA

Autophagy inhibition to sensitize colon cancer to anti-angiogenic therapy$554,048

R01 · FY2011 · CA · contact PI

Therapeutic Micro RNA Strategies for Ovarian Cancer$496,164

P50 · FY2011 · CA

Interaction of anti-angiogenic and cytotoxic therapies in colorectal cancer$652,384

R01 · FY2010 · CA · contact PI

Therapeutic Micro RNA Strategies for Ovarian Cancer$522,716

P50 · FY2010 · CA

Interaction of anti-angiogenic and cytotoxic therapies in colorectal cancer$661,447

R01 · FY2009 · CA · contact PI

Therapeutic Micro RNA Strategies for Ovarian Cancer$423,111

P50 · FY2009 · CA

Determinants of response to bevacizumab in colon cancer$136,310

R21 · FY2006 · CA · contact PI

Determinants of response to bevacizumab in colon cancer$136,310

R21 · FY2005 · CA

GENE EXPRESSION AND HYPOXIC CELL RESISTANCE$387,637

R01 · FY2004 · CA

GENE EXPRESSION AND HYPOXIC CELL RESISTANCE$376,559

R01 · FY2003 · CA

MECHANISMS OF CHEMOPROTECTION BY OLTIPRAZ$298,046

R01 · FY2003 · CA

GENE EXPRESSION AND HYPOXIC CELL RESISTANCE$365,745

R01 · FY2002 · CA

MECHANISMS OF CHEMOPROTECTION BY OLTIPRAZ$289,366

R01 · FY2002 · CA

GENE EXPRESSION AND HYPOXIC CELL RESISTANCE$355,850

R01 · FY2001 · CA

MECHANISMS OF CHEMOPROTECTION BY OLTIPRAZ$281,611

R01 · FY2001 · CA

GENE EXPRESSION AND HYPOXIC CELL RESISTANCE$384,058

R01 · FY2000 · CA

MECHANISMS OF CHEMOPROTECTION BY OLTIPRAZ$302,474

R01 · FY2000 · CA